Rezultati pretrage - Allan Dunlop

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients od Neil Chanchlani, Simeng Lin, Desmond Chee, Benjamin Hamilton, Rachel Nice, Zehra Arkir, Claire Bewshea, Bessie Cipriano, L Derikx, Allan Dunlop, Louise Greathead, Rachel L Griffiths, Hajir Ibraheim, Peter Kelleher, Klaartje Kok, Charlie W. Lees, Jonathan Macdonald, Shaji Sebastian, Philip J Smith, Timothy J. McDonald, Peter M. Irving, Nick Powell, Nicholas A. Kennedy, James Goodhand, Tariq Ahmad